Literature DB >> 20649409

The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.

Sara Haug1, Takele Lakew, Gabremaskal Habtemariam, Wondu Alemayehu, Vicky Cevallos, Zhaoxia Zhou, Jenafir House, Kathryn Ray, Travis Porco, Tina Rutar, Jeremy Keenan, Thomas M Lietman, Bruce D Gaynor.   

Abstract

After 6 biannual mass distributions of oral azithromycin for trachoma in Ethiopian communities, 76.8% (95% confidence interval [CI], 66.3%-85.1%) of nasopharyngeal Streptococcus pneumoniae isolates from children aged 1-5 years were resistant to macrolides. Twelve and 24 months after the last azithromycin treatment, resistance decreased to 30.6% (95% CI, 18.8%-40.4%; P <.001 ) and 20.8% (95% CI, 12.7%-30.7%; P < .001), respectively. Macrolide resistance decreases after antibiotic pressure is removed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20649409     DOI: 10.1086/655697

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  50 in total

1.  Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting.

Authors:  Daozhou Gao; Thomas M Lietman; Travis C Porco
Journal:  Math Biosci       Date:  2015-02-26       Impact factor: 2.144

2.  Antimicrobial susceptibility patterns of Streptococcus pneumoniae over 6 years at Gondar University Hospital, Northwest Ethiopia.

Authors:  Belay Anagaw; Mucheye Gezachew; Fantahun Biadgelgene; Berhanu Anagaw; Tariku Geleshe; Birke Taddese; Birhanu Getie; Mengistu Endris; Andargachew Mulu; Chandrashekhar Unakal
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

3.  Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

Authors:  Jessica C Seidman; Christian L Coles; Ellen K Silbergeld; Joshua Levens; Harran Mkocha; Lashaunda B Johnson; Beatriz Muñoz; Sheila K West
Journal:  Int J Epidemiol       Date:  2014-03-21       Impact factor: 7.196

4.  Association of conjunctival bacterial infection and female sex in cicatricial trachoma.

Authors:  Vicky Cevallos; John P Whitcher; Muluken Melese; Wondu Alemayehu; Elizabeth Yi; Jaya D Chidambaram; Scott Lee; Harsha Reddy; Bruce D Gaynor; Thomas M Lietman; Jeremy D Keenan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-07       Impact factor: 4.799

5.  Association of community antibiotic consumption with clinically active trachoma in rural Ethiopia.

Authors:  Berhan Ayele; Tesfaye Belay; Teshome Gebre; Mulat Zerihun; Abayneh Amere; Yared Assefa; Dereje Habte; Allison R Loh; Nicole E Stoller; Jeremy D Keenan
Journal:  Int Health       Date:  2011-12       Impact factor: 2.473

Review 6.  Ocular Chlamydia trachomatis infection: elimination with mass drug administration.

Authors:  Meraf A Wolle; Sheila K West
Journal:  Expert Rev Anti Infect Ther       Date:  2019-02-18       Impact factor: 5.091

7.  Antibiotic Resistance in Young Children in Kilosa District, Tanzania 4 Years after Mass Distribution of Azithromycin for Trachoma Control.

Authors:  Evan M Bloch; Sheila K West; Kasubi Mabula; Jerusha Weaver; Zakayo Mrango; Beatriz Munoz; Thomas Lietman; Christian Coles
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

8.  Coinfection Dynamics of Two Diseases in a Single Host Population.

Authors:  Daozhou Gao; Travis C Porco; Shigui Ruan
Journal:  J Math Anal Appl       Date:  2016-04-19       Impact factor: 1.583

9.  Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Authors:  K M Hare; K Grimwood; A B Chang; M D Chatfield; P C Valery; A J Leach; H C Smith-Vaughan; P S Morris; C A Byrnes; P J Torzillo; A C Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-12       Impact factor: 3.267

10.  Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.

Authors:  Abdou Amza; Boubacar Kadri; Beido Nassirou; Sun Y Cotter; Nicole E Stoller; Sheila K West; Robin L Bailey; Travis C Porco; Bruce D Gaynor; Jeremy D Keenan; Thomas M Lietman; Catherine E Oldenburg
Journal:  Br J Ophthalmol       Date:  2017-09-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.